Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

The effect of mesna on plasma total homocysteine concentration in hemodialysis patients.

Urquhart BL, Freeman DJ, Spence JD, House AA.

Am J Kidney Dis. 2007 Jan;49(1):109-17.

PMID:
17185151
2.

Mesna for the treatment of hyperhomocysteinemia in hemodialysis patients.

Cutler MJ, Urquhart BL, Freeman DJ, Spence JD, House AA.

Blood Purif. 2009;27(3):306-10. doi: 10.1159/000207197. Epub 2009 Mar 9.

PMID:
19270449
3.

Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.

Urquhart BL, Freeman DJ, Cutler MJ, Mainra R, Spence JD, House AA.

Clin J Am Soc Nephrol. 2008 Jul;3(4):1041-7. doi: 10.2215/CJN.04771107. Epub 2008 Mar 12.

4.

The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.

Sombolos K, Fragia T, Natse T, Bartholomatos G, Karagianni A, Katsaris G, Christidou F, Bamichas G, Stangou M, Papagalanis N.

J Nephrol. 2002 Nov-Dec;15(6):671-5.

PMID:
12495282
5.

[The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].

Lovcić V, Kes P, Zeljko R, Kusec V.

Acta Med Croatica. 2006 Jun;60(3):201-8. Croatian.

PMID:
16933832
6.

Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients.

Obeid R, Kuhlmann MK, Köhler H, Herrmann W.

Clin Chem. 2005 Jan;51(1):196-201. Epub 2004 Nov 4.

7.

Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients.

Skoupy S, Födinger M, Veitl M, Perschl A, Puttinger H, Röhrer C, Schindler K, Vychytil A, Hörl WH, Sunder-Plassmann G.

J Am Soc Nephrol. 2002 May;13(5):1331-7.

8.

[Characteristics of hyperhomocysteinemia in dialysis patients].

Lovcić V, Kes P, Reiner Z.

Acta Med Croatica. 2006;60(1):21-6. Croatian.

PMID:
16802568
9.

Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients.

De Vriese AS, Langlois M, Bernard D, Geerolf I, Stevens L, Boelaert JR, Schurgers M, Matthys E.

Nephrol Dial Transplant. 2003 Dec;18(12):2596-600.

PMID:
14605283
10.

Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.

Sjöberg B, Anderstam B, Suliman M, Alvestrand A.

Am J Kidney Dis. 2006 Jan;47(1):60-71.

PMID:
16377386
11.

The effect of two different doses comprising the simultaneous administration of intravenous B-complex vitamins and oral folic acid on serum homocysteine levels in hemodialysis patients.

Sombolos K, Papaioannou A, Christidou F, Natse T, Bamichas G, Gionanlis L, Katsaris G, Progia E.

Int Urol Nephrol. 2006;38(3-4):725-30.

PMID:
17115295
12.

Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.

Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M.

Nephrology (Carlton). 2008 Jun;13(4):284-8. doi: 10.1111/j.1440-1797.2008.00934.x. Epub 2008 Mar 5.

PMID:
18331436
14.

The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.

Suliman M, Stenvinkel P, Qureshi AR, Kalantar-Zadeh K, Bárány P, Heimbürger O, Vonesh EF, Lindholm B.

Nephrol Dial Transplant. 2007 Jan;22(1):209-17. Epub 2006 Sep 17.

PMID:
16982634
15.

Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.

House AA, Eliasziw M, Urquhart BL, Freeman DJ, Spence JD.

Am J Kidney Dis. 2004 Oct;44(4):689-94.

PMID:
15384020
16.

Elevated homocysteine levels in patients with end-stage renal disease.

Nair AP, Nemirovsky D, Kim M, Geer EB, Farkouh ME, Winston J, Halperin JL, Robbins MJ.

Mt Sinai J Med. 2005 Nov;72(6):365-73.

PMID:
16358160
17.

Cobalamin dose regimen for maximum homocysteine reduction in end-stage renal disease.

Hoffer LJ, Saboohi F, Golden M, Barré PE.

Metabolism. 2005 Jun;54(6):835-40.

PMID:
15931623
18.
19.

Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.

Akgul A, Bilgic A, Sezer S, Arat Z, Ozdemir FN, Haberal M.

J Ren Nutr. 2008 Jul;18(4):338-46. doi: 10.1053/j.jrn.2007.11.007.

PMID:
18558298
20.

Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis.

Friedman AN, Bostom AG, Levey AS, Rosenberg IH, Selhub J, Pierratos A.

J Am Soc Nephrol. 2002 Jan;13(1):265-8.

Supplemental Content

Support Center